An interdisciplinary team at the USC Center for Personalized Brain Health (CPBH) is targeting a family of enzymes that can increase the risk of inflammation in the brains of people with the APOE4 gene variation-the most significant genetic risk factor for late-onset Alzheimer's-as a way to prevent the disease.

A new study from Karolinska Institutet has shown that the amount and distribution of the tau protein in the brain differs between early- and late-onset Alzheimer's disease. The results also indicate that ...